ストックスクリーナーアプリを入手
55.92
3.86%
2.08
Keros Therapeutics Inc (KROS) 最新ニュース
Cantor Fitzgerald Reaffirms Overweight Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Keros Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Keros Therapeutics Reports Q3 2024 Financial Results - TipRanks
Long Term Trading Analysis for (KROS) - Stock Traders Daily
What is Leerink Partnrs’ Estimate for KROS FY2024 Earnings? - Defense World
Equities Analysts Offer Predictions for KROS FY2024 Earnings - Defense World
What is HC Wainwright's Estimate for KROS FY2024 Earnings? - MarketBeat
Wedbush Decreases Earnings Estimates for Keros Therapeutics - MarketBeat
William Blair Issues Pessimistic Forecast for KROS Earnings - MarketBeat
Leerink Partnrs Has Negative Outlook of KROS FY2024 Earnings - MarketBeat
Wedbush Equities Analysts Cut Earnings Estimates for KROS - Defense World
FY2024 Earnings Estimate for KROS Issued By HC Wainwright - Defense World
Keros Therapeutics (NASDAQ:KROS) Now Covered by Jefferies Financial Group - Defense World
Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023) - Yahoo Finance
Brokers Offer Predictions for KROS Q3 Earnings - Defense World
Q3 Earnings Estimate for KROS Issued By Wedbush - MarketBeat
Interesting KROS Put And Call Options For April 2025 - Nasdaq
HC Wainwright Reaffirms Buy Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Brokers Set Expectations for KROS Q4 Earnings - Defense World
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results - GlobeNewswire
KROSKeros Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Keros Therapeutics to Present at Guggenheim Conference - TipRanks
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference - The Manila Times
Brokers Issue Forecasts for KROS Q4 Earnings - MarketBeat
Wedbush Upgrades Keros Therapeutics (NASDAQ:KROS) to Strong-Buy - MarketBeat
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition - GlobeNewswire
Jefferies starts Keros Therapeutics with buy, $107 target By Investing.com - Investing.com Canada
(KROS) Proactive Strategies - Stock Traders Daily
Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Emerald Advisers LLC Acquires Shares of 155,545 Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) PT at $89.11 - Defense World
Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Update - MarketBeat
Analysts Offer Predictions for KROS FY2024 Earnings - Defense World
Assenagon Asset Management S.A. Boosts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World
Brokers Set Expectations for KROS FY2024 Earnings - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World
(KROS) Trading Signals - Stock Traders Daily
Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating - Investing.com India
Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating By Investing.com - Investing.com South Africa
Cantor Fitzgerald Initiates Coverage on Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Now Covered by Scotiabank - MarketBeat
Keros Therapeutics appoints new Chief Medical Officer - Investing.com
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire
Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com UK
Keros Therapeutics, Inc. Appoints Yung H. Chyung as Chief Medical Officer, Effective as of November 1, 2024 - Marketscreener.com
Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Declines By 13.7% - MarketBeat
Objective long/short (KROS) Report - Stock Traders Daily
Renaissance Technologies LLC Invests $654,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Renaissance Technologies LLC Acquires New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
1.89%
2.08%
大文字化:
|
ボリューム (24 時間):